Intercept Pharmaceuticals reported $8.26M in Stock for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 6.33M 0.68M
Alnylam Pharmaceuticals ALNY:US $ 88.98M 10.46M
Amarin AMRN:US $ 225.77M 42.05M
Amgen AMGN:US $ 4554M 143M
Biogen BIIB:US $ 1294.2M 78.8M
Bristol Myers Squibb BMY:US $ 2142M 38M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Esperion Therapeutics ESPR:US $ 29.23M 6.42M
Gilead Sciences GILD:US $ 2587M 88M
GlaxoSmithKline GSK:LN 466400M 133900M
IONIS PHARMACEUT IONS:US $ 19.81M 4.22M
Moderna Inc MRNA:US 1.92B 21M
Neurocrine Biosciences NBIX:US $ 29.3M 0.3M
Novartis NOVN:VX SF 6880M 117M
Ptc Therapeutics PTCT:US $ 15M 0.28M
Regeneron Pharmaceuticals REGN:US $ 2218.5M 227M
Sarepta Therapeutics SRPT:US $ 208.1M 9.1M
Vertex Pharmaceuticals VRTX:US $ 367.7M 28.8M
YTE INCY:US $ 54.5M 19.05M